Plans to initiate Phase 2 clinical trial in Adrenocortical Carcinoma in early 2026 through unique partnership between Cytovation, Cancer Research UK and the Norwegian Cancer Society
You might also be interested in reading Crypto.com Expands Prediction Markets Into Hollywood Entertainment.